nubeqa (darolutamide), a hormone therapy | ask a prostate expert, mark scholz, md
Published 3 years ago • 4.9K plays • Length 3:57
Download video MP4
Download video MP3
Similar videos
-
7:00
comparing the second generation hormone therapies | ask a prostate expert, mark scholz, md
-
9:12
orgovyx, nubeqa, & early taxotere | 2021 treatments in review | mark scholz, md
-
12:08
new fda approval: darolutamide for hormone-sensitive disease | mark scholz, md | pcri
-
7:42
combination therapy & hormone therapy | ask a prostate expert, mark scholz, md
-
6:46
what is nubeqa for prostate cancer and how does it work? | ask a prostate expert, mark scholz, md
-
5:42
immune, hormone, & radiation combined for prostate cancer | ask a prostate expert, mark scholz, md
-
6:21
what is adjuvant hormone therapy for prostate cancer | ask a prostate expert, mark scholz, md
-
4:50
tips for managing hormone therapy side effects | ask a prostate cancer expert, mark scholz, md
-
3:59
hormone therapy basics | ask a prostate cancer expert, mark scholz, md
-
7:46
treating non-metastatic castrate resistant prostate cancer | ask a prostate expert, mark scholz, md
-
6:02
high-risk prostate cancer: hormone therapy after surgery | ask a prostate expert, mark scholz, md
-
4:49
keytruda for prostate cancer | ask a prostate expert, mark scholz, md
-
3:50
darolutamide (nubeqa) lupron for high risk prostate cancer | learn about clinical trials
-
4:54
immunotherapy & prostate cancer | ask a prostate expert, mark scholz, md
-
9:56
intermittent hormone therapy for prostate cancer 101 | ask a prostate expert, mark scholz, md
-
5:57
who are candidates for adjuvant therapy in prostate cancer? | ask a prostate expert, mark scholz, md
-
1:36
fda approves bayer's nubeqa (darolutamide) for non-metastatic castration-resistant prostate cancer
-
5:56
stories of advanced prostate cancer survivors | ask a prostate expert, mark scholz, md
-
4:32
prostate cancer chemotherapy basics | ask a prostate expert, mark scholz, md
Clip.africa.com - Privacy-policy